PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 7.77

Change

-0.29 (-3.60)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-25 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
TQQQ ProShares UltraPro QQQ

+0.02 (+0.03%)

USD 23.50B
SOXL Direxion Daily Semiconductor B..

+0.67 (+1.91%)

USD 12.27B
QLD ProShares Ultra QQQ

+0.19 (+0.19%)

USD 6.60B
FNGU MicroSectors FANG+ Index 3X Le..

-2.30 (-0.55%)

USD 5.40B
SSO ProShares Ultra S&P500

-0.58 (-0.65%)

USD 4.93B
UPRO ProShares UltraPro S&P500

-0.84 (-0.98%)

USD 4.05B
TECL Direxion Daily Technology Bull..

+0.77 (+0.90%)

USD 3.28B
YINN Direxion Daily FTSE China Bull..

-2.62 (-7.98%)

USD 1.15B
USD ProShares Ultra Semiconductors

+3.46 (+2.93%)

USD 1.02B
LABU Direxion Daily S&P Biotech Bul..

-3.92 (-3.05%)

USD 0.99B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.26% 16% F 25% F
Dividend Return 1.00% 54% F 20% F
Total Return 1.26% 16% F 23% F
Trailing 12 Months  
Capital Gain 6.00% 16% F 30% F
Dividend Return 1.58% 38% F 23% F
Total Return 7.59% 15% F 26% F
Trailing 5 Years  
Capital Gain -37.94% 25% F 13% F
Dividend Return 2.10% 34% F 6% D-
Total Return -35.84% 24% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain -2.93% 10% F 23% F
Dividend Return -2.45% 10% F 14% F
Total Return 0.48% 37% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 105.69% 36% F 7% C-
Risk Adjusted Return -2.32% 10% F 23% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.